Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–32.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. (2021): Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 71:209–49.

Zheng R, Zhang S, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Cent. 2022;2:1–9.

Article  Google Scholar 

Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–9.

Article  CAS  PubMed  Google Scholar 

Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, et al. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res. 2010;70:3159–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mo Y, Ma J, Zhang H, Shen J, Chen J, Hong J, et al. Prophylactic and therapeutic HPV vaccines: current scenario and perspectives. Front Cell Infect Microbiol. 2022;12:909223.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Q, Liu YJ, Hu SY, Zhao FH. Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China. BMC Cancer. 2016;16:848.

Article  PubMed  PubMed Central  Google Scholar 

Gay JD, Donaldson LD, Goellner JR. False-negative results in cervical cytologic studies. Acta Cytol. 1985;29:1043–6.

CAS  PubMed  Google Scholar 

Zhao FH, Lewkowitz AK, Chen F, Lin MJ, Hu SY, Zhang X, et al. Pooled analysis of a self-sampling HPV DNA test as a cervical cancer primary screening method. J Natl Cancer Inst. 2012;104:178–88.

Article  PubMed  PubMed Central  Google Scholar 

Gravitt PE, Winer RL. Natural history of HPV infection across the lifespan: role of viral latency. Viruses. 2017;9:267.

Article  PubMed  PubMed Central  Google Scholar 

Benevolo M, Vocaturo A, Caraceni D, French D, Rosini S, Zappacosta R, et al. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test. J Clin Microbiol. 2011;49:2643–50.

Article  PubMed  PubMed Central  Google Scholar 

Ge Y, Christensen P, Luna E, Armylagos D, Xu J, Schwartz MR, et al. Aptima Human Papillomavirus E6/E7 mRNA test results strongly Associated with Risk for High-Grade Cervical Lesions in Follow-Up Biopsies. J Low Genit Tract Dis. 2018;22:195–200.

Article  PubMed  Google Scholar 

Heideman DA, Hesselink AT, van Kemenade FJ, Iftner T, Berkhof J, Topal F, et al. The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screening. J Clin Microbiol. 2013;51:3653–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arbyn M, Simon M, de Sanjose S, Clarke MA, Poljak M, Rezhake R, et al. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis. Lancet Oncol. 2022;23:950–60.

Article  CAS  PubMed  Google Scholar 

Zhang SK, Guo Z, Wang P, Kang LN, Jia MM, Wu ZN, et al. The potential benefits of HPV E6/E7 mRNA test in cervical cancer screening in China. Front Oncol. 2020;10:533253.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Yang D, Cui X, Liu G, Cui Z, Wang C, et al. Performance of human papillomavirus E6/E7 mRNA assay for primary cervical cancer screening and triage: population-based screening in China. Front Cell Infect Microbiol. 2022;12:935071.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang J, Du Y, Dong J, Zhou Y, Wang P, Zhang X, et al. Clinical significance of genotyping for human papillomavirus (HPV) 16 18/45 combined with cytology in cervical exfoliated cells in HPV oncogenic mRNA-positive women. Gynecol Oncol. 2019;153:34–40.

Article  CAS  PubMed  Google Scholar 

Waxman AG, Chelmow D, Darragh TM, Lawson H, Moscicki AB. Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix. Obstet Gynecol. 2012;120:1465–71.

Article  PubMed  PubMed Central  Google Scholar 

Haedicke J, Iftner T. A review of the clinical performance of the Aptima HPV assay. J Clin Virol. 2016;76(Suppl 1):40–8.

Article  Google Scholar 

Reid JL, Wright TC Jr, Stoler MH, Cuzick J, Castle PE, Dockter J, et al. Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study. Am J Clin Pathol. 2015;144:473–83.

Article  CAS  PubMed  Google Scholar 

Li J, Huang R, Schmidt JE, Qiao YL. Epidemiological features of human papillomavirus (HPV) infection among women living in Mainland China. Asian Pac J Cancer Prev. 2013;14:4015–23.

Article  PubMed  Google Scholar 

Arbyn M, Simon M, Peeters E, Xu L, Meijer C, Berkhof J, et al. 2020 list of human papillomavirus assays suitable for primary cervical cancer screening. Clin Microbiol Infect. 2021;27:1083–95.

Article  CAS  PubMed  Google Scholar 

Vinokurova S, Wentzensen N, Kraus I, Klaes R, Driesch C, Melsheimer P, et al. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res. 2008;68:307–13.

Article  CAS  PubMed  Google Scholar 

de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048–56.

Article  PubMed  Google Scholar 

Castle PE, Cuzick J, Stoler MH, Wright TC Jr, Reid JL, Dockter J, et al. Detection of human papillomavirus 16, 18, and 45 in women with ASC-US cytology and the risk of cervical precancer: results from the CLEAR HPV study. Am J Clin Pathol. 2015;143:160–7.

Article  PubMed  Google Scholar 

Stoler MH, Wright TC Jr, Sharma A, Apple R, Gutekunst K, Wright TL, et al. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol. 2011;135:468–75.

Article  PubMed  Google Scholar 

Stoler MH, Wright TC Jr, Sharma A, Zhang G, Apple R, Wright TL, et al. The interplay of age stratification and HPV testing on the predictive value of ASC-US cytology. Results from the ATHENA HPV study. Am J Clin Pathol. 2012;137:295–303.

Article  PubMed  Google Scholar 

Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2020;24:102–31.

Article  PubMed  PubMed Central  Google Scholar 

Egemen D, Cheung LC, Chen X, Demarco M, Perkins RB, Kinney W, et al. Risk estimates supporting the 2019 ASCCP risk-based Management Consensus Guidelines. J Low Genit Tract Dis. 2020;24:132–43.

Article  PubMed  PubMed Central  Google Scholar